ADIPOQ and obesity due to melanocortin 4 receptor deficiency: Adiponectin which has anti-hyperglycemic, anti-atherogenic, and anti-inflammatory properties, could have important clinical benefits in terms of development of therapies for the prevention and for the treatment of obesity and obesity-related diseases [27].